Avalo Therapeutics 뉴스 - AVTX

기업명	주식 심볼	시장	주식 타입
Avalo Therapeutics Inc	AVTX	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	-0.50	-3.12%	15.50	08:50:01

개장가	저가	고가	종가	전일 종가
16.20	15.39	17.42	15.39	16.00

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
02/04/2024	20:00	GLOBE	Avalo Therapeutics Appoints Biotech Leaders to Board of..
30/03/2024	05:01	GLOBE	Avalo Reports 2023 Financial Results and Provides Business..
28/03/2024	05:01	GLOBE	Avalo Acquires Anti-IL-1β mAb and Announces Private..
15/02/2024	11:13	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
15/02/2024	00:02	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
01/02/2024	06:01	EDGAR2	Form 8-K - Current report
29/12/2023	07:05	EDGAR2	Form 8-K - Current report
27/12/2023	21:00	GLOBE	Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
22/12/2023	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
22/12/2023	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
21/12/2023	06:01	EDGAR2	Form 8-K - Current report
07/12/2023	21:02	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
07/12/2023	21:01	EDGAR2	Form 8-K - Current report
07/12/2023	21:00	GLOBE	Avalo Encourages Stockholders to Vote FOR the Reverse Stock..
16/11/2023	21:15	EDGAR2	Form 8-K - Current report
09/11/2023	21:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/2023	21:04	EDGAR2	Form 8-K - Current report
09/11/2023	21:00	GLOBE	Avalo Reports Third Quarter 2023 Financial Results and..
31/10/2023	20:21	EDGAR2	Form 8-K - Current report
31/10/2023	20:00	GLOBE	Avalo Completes Divestiture of AVTX-800 Series
20/10/2023	05:15	EDGAR2	Form ARS - Annual Report to Security Holders
20/10/2023	05:06	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
20/10/2023	05:01	EDGAR2	Form DEF 14A - Other definitive proxy statements
18/10/2023	05:02	EDGAR2	Form 8-K - Current report
06/10/2023	05:02	EDGAR2	Form PRE 14A - Other preliminary proxy statements
26/09/2023	20:04	EDGAR2	Form 8-K - Current report
26/09/2023	20:00	GLOBE	Avalo Therapeutics Successfully Eliminates $35 Million Debt..
14/09/2023	05:03	EDGAR2	Form 8-K - Current report
13/09/2023	22:12	EDGAR2	Form 8-K - Current report
12/09/2023	20:10	EDGAR2	Form 8-K - Current report
12/09/2023	20:00	GLOBE	Avalo Enters into Agreement to Divest AVTX-800 Series
11/09/2023	20:22	EDGAR2	Form 8-K - Current report
06/09/2023	20:00	GLOBE	Avalo to Present at the H.C. Wainwright 25th Annual Global..
15/08/2023	05:23	EDGAR2	Form 8-K - Current report
09/08/2023	05:11	EDGAR2	Form 8-K - Current report
08/08/2023	06:27	EDGAR2	Form 8-K - Current report
08/08/2023	06:26	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
03/08/2023	20:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/2023	20:01	EDGAR2	Form 8-K - Current report
03/08/2023	20:00	GLOBE	Avalo Reports Second Quarter 2023 Financial Results and..
21/07/2023	21:25	EDGAR2	Form 8-K - Current report
07/07/2023	05:01	GLOBE	Avalo to Participate in SVB Securities Therapeutics Forum
29/06/2023	21:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
29/06/2023	07:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
26/06/2023	20:00	GLOBE	Avalo Announces Topline Data from Phase 2 PEAK Trial for..
01/06/2023	20:00	GLOBE	Avalo to Present at the Jefferies Healthcare Conference
22/05/2023	20:00	GLOBE	Avalo Announces Appointment of Michael Croft, Ph.D. and Jeff..
15/05/2023	20:00	GLOBE	Avalo to Present at ATS 2023 Respiratory Innovation Summit
10/05/2023	20:00	GLOBE	Avalo to Present at the 2023 RBC Capital Markets Global..
05/05/2023	05:01	GLOBE	Avalo Reports First Quarter 2023 Financial Results and..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

AVTX Avalo Therapeutics Inc

최근 뉴스

AVTX 과거 데이터 - 1일

AVTX 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Avalo Therapeutics Inc (AVTX) 뉴스

AVTX Avalo Therapeutics Inc

최근 뉴스

AVTX 과거 데이터 - 1일

AVTX 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기